Blau Farmacêutica S.A.

BOVESPA:BLAU3 Rapport sur les actions

Capitalisation boursière : R$2.7b

Blau Farmacêutica Bilan de santé

Santé financière contrôle des critères 6/6

Blau Farmacêutica possède un total de capitaux propres de R$2.1B et une dette totale de R$509.8M, ce qui porte son ratio d'endettement à 24.5%. Son actif total et son passif total sont R$3.2B et de R$1.2B. L'EBIT de Blau Farmacêutica est R$265.9M ce qui fait que son ratio de couverture des intérêts 18.6. Elle dispose de liquidités et de placements à court terme de R$431.9M.

Informations clés

24.5%

Ratio d'endettement

R$509.83m

Dette

Ratio de couverture des intérêts18.6x
Argent liquideR$431.95m
Fonds propresR$2.08b
Total du passifR$1.16b
Total des actifsR$3.24b

Mises à jour récentes de la santé financière

Is Blau Farmacêutica (BVMF:BLAU3) A Risky Investment?

Jun 28
Is Blau Farmacêutica (BVMF:BLAU3) A Risky Investment?

Recent updates

Results: Blau Farmacêutica S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates

Nov 07
Results: Blau Farmacêutica S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates

Blau Farmacêutica S.A.'s (BVMF:BLAU3) 25% Share Price Surge Not Quite Adding Up

Nov 06
Blau Farmacêutica S.A.'s (BVMF:BLAU3) 25% Share Price Surge Not Quite Adding Up

Blau Farmacêutica S.A.'s (BVMF:BLAU3) 31% Price Boost Is Out Of Tune With Earnings

Aug 29
Blau Farmacêutica S.A.'s (BVMF:BLAU3) 31% Price Boost Is Out Of Tune With Earnings

Is Blau Farmacêutica (BVMF:BLAU3) A Risky Investment?

Jun 28
Is Blau Farmacêutica (BVMF:BLAU3) A Risky Investment?

Lacklustre Performance Is Driving Blau Farmacêutica S.A.'s (BVMF:BLAU3) 26% Price Drop

Feb 01
Lacklustre Performance Is Driving Blau Farmacêutica S.A.'s (BVMF:BLAU3) 26% Price Drop

What Does The Future Hold For Blau Farmacêutica S.A. (BVMF:BLAU3)? These Analysts Have Been Cutting Their Estimates

May 14
What Does The Future Hold For Blau Farmacêutica S.A. (BVMF:BLAU3)? These Analysts Have Been Cutting Their Estimates

Blau Farmacêutica S.A. Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next

Feb 24
Blau Farmacêutica S.A. Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next

Getting In Cheap On Blau Farmacêutica S.A. (BVMF:BLAU3) Is Unlikely

Oct 14
Getting In Cheap On Blau Farmacêutica S.A. (BVMF:BLAU3) Is Unlikely

Robust Earnings May Not Tell The Whole Story For Blau Farmacêutica (BVMF:BLAU3)

Aug 17
Robust Earnings May Not Tell The Whole Story For Blau Farmacêutica (BVMF:BLAU3)

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de BLAU3 ( R$1.6B ) dépassent ses passifs à court terme ( R$455.8M ).

Passif à long terme: Les actifs à court terme de BLAU3 ( R$1.6B ) dépassent ses passifs à long terme ( R$701.0M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de BLAU3 ( 3.7% ) est considéré comme satisfaisant.

Réduire la dette: Le ratio d'endettement de BLAU3 a été réduit de 91.5% à 24.5% au cours des 5 dernières années.

Couverture de la dette: La dette de BLAU3 est bien couverte par le flux de trésorerie opérationnel ( 65.2% ).

Couverture des intérêts: Les paiements d'intérêts de BLAU3 sur sa dette sont bien couverts par l'EBIT ( 18.6 x couverture).

Bilan

Découvrir des entreprises saines

7D

1Y

7D

1Y

7D

1Y